Tag: Side Effects
Adverse Reactions to BNT162b2 Mild, Moderate for 5- to 11-Year-Olds
Based on data from three U.S. safety monitoring systems, adverse events were mild-to-moderate, and myocarditis occurred rarely
Hormone Therapy-Related Hot Flashes Tied to Worse Breast Cancer Outcomes
Findings for chemotherapy-free patients with breast cancer
Veterans Report Low Rates of Adverse Events With mRNA Vaccines
Rates slightly higher at 42 days for those receiving Pfizer versus Moderna
One in Nine May Get Delayed Large Local Reaction After Moderna Vaccine
Higher risk seen among women and among individuals aged 30 to 69 years
AE Risk Examined for Abiraterone, Enzalutamide in Prostate Cancer
Risk for metabolic or cardiovascular adverse events increased for men receiving abiraterone or enzalutamide for advanced disease
Risk for Guillain-Barré Syndrome Up After Ad.26.COV2.S Vaccination
Adjusted rate ratio of 20.56 found in head-to-head comparison of Ad.26.COV2.S with mRNA COVID-19 vaccines
Drug Interaction Checkers Could Have Caught Adverse Events
More than three-quarters of COVID-19-associated drug-drug interactions could have been identified
Adverse Effects Generally Mild After BNT162b2 mRNA Booster in Over 60s
Thirty percent of those aged 60 years or older receiving booster reported at least one AE; few sought medical attention
Women Face Higher Risk for Severe AEs From Cancer Therapy
Large differences in risks for severe adverse events according to sex seen for cancer patients receiving immunotherapy
Methotrexate-Related AEs Profiled in Early Rheumatoid Arthritis
Adverse events common during first year of methotrexate therapy for early rheumatoid arthritis, but most not serious
